bf/NASDAQ:ACER_icon.jpeg

NASDAQ:ACER

Acer Therapeutics Inc.

  • Stock

0.66

−17.95%

−0.14

USD last updated 15/08 02:20:07

Last Close

0.80

20/11 20:59

Market Cap

16.15M

Beta: 0.57

Volume Today

574.67K

Avg: 328.16K

PE Ratio

−0.27

PFCF: −0.41

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation o...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -20-15-10-52015-02-232017-03-272018-11-092020-11-102022-11-14

    Revenue (Estimate*)

    2M4M6M8M10M2015-02-232017-03-272018-11-092020-11-102022-11-14

    *Estimate based on analyst consensus